Open

Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)

Federal funding opportunity PAR-25-103 from National Institutes of Health (Department of Health and Human Services).

Apply on Grants.gov →Application closes October 25, 2027

Posted: November 5, 2024
Closes: October 25, 2027
Cost sharing: No
Instrument: Cooperative Agreement
Assistance listing: 93.399
Category: Education, Health
Archives: November 30, 2027

Program funding history

Awards made under Assistance Listing 93.399 across FY2025–FY2027, from public federal spending records.

FY2025 obligated: $172.1M
FY2026 obligated: $164.8M
FY2027 (to date) obligated: $0
Awards in window: 141

Top recipients: Ecog-acrin Medical Research Foundation, Inc., Nrg Oncology Foundation Inc, Alliance Nctn Foundation, University of Rochester, Fred Hutchinson Cancer Center

Source: USAspending.gov · refreshed October 2026 · Program page: awards, recipients and the opportunities under this listing →

Synopsis

The purpose of this NOFO is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related symptoms, supportive care, and the long-term outcomes of cancer survivors. Although the scientific literature or preliminary data may provide the rationale for conducting a clinical trial, investigators often lack critical information about the study population, accrual challenges, intervention, outcome/ endpoints, data/statistical challenges or operational risks necessary to finalize the trial protocol completely. These information gaps can result in multiple protocol changes before and after trial start-up, leading to the need for additional time and expenses that may prevent study completion. Further, the suitability and feasibility of new trial designs, which minimize infrastructure and reduce costs may need to be tested in the context of a particular intervention, at-risk group, symptom or venue. Preparatory studies may fill information gaps and address unknowns, improving trial design and knowledge of trial feasibility and thus saving NCI time and money.

Who can apply

Private institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Public housing authorities/Indian housing authorities
Public and State controlled institutions of higher education
State governments
Native American tribal governments (Federally recognized)
Native American tribal organizations (other than Federally recognized tribal governments)
Small businesses
For profit organizations other than small businesses
County governments
Special district governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Independent school districts

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

How to apply

Applications go through the official government listing. Grants Radar links you straight to the source — applying is free.

View on Grants.gov Full announcement

Agency contact: National Institutes of Health · [email protected] · 301-402-2541

New to federal funding? How to read an announcement · Who can apply · How grants work

Remind me before this closes

One email about a week before this grant closes (the next morning, if it is already closer than that). That is all this sends — it is not a newsletter signup.

Stored once per grant, used only for this watch’s emails; every one carries a one-click unsubscribe. Privacy

Get grants like this every Tuesday — free

One email a week: the biggest new federal grants and what’s closing soon — the same list for everyone. Unsubscribe any time.

No spam, ever. Privacy

Similar grants

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
PAR-25-104 · National Institutes of Health · closes October 25, 2027
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
PAR-25-167 · National Institutes of Health · closes January 7, 2027
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
PAR-25-081 · National Institutes of Health · closes January 7, 2027
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
PA-25-172 · National Institutes of Health · closes January 7, 2028
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
PA-25-253 · National Institutes of Health · closes September 7, 2028
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
RFA-CA-27-019 · National Institutes of Health · closes October 19, 2027

Same-day alerts, matched to you

The free digest is weekly — the same list for everyone. Members get every open federal grant scored to their organization — and an alert the day a real match posts: we read every new posting the day it opens. Free for 30 days, then $29/mo. Card required, cancel any time before day 31.

Not ready for a subscription? A one-time Fit Report — $29 — scores every open federal grant to your organization once, by email within one business day.

See pricing